Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(0)
# 4956
Out of 5,240 analysts
279
Total ratings
19.80%
Success rate
-33.74%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Ventyx Biosciences | Reiterates: Neutral | n/a | n/a | n/a | 15 | Jan 14, 2025 | |
NovoCure | Reiterates: Buy | 38 38 | 26.29 | 44.54% | 18 | Jan 14, 2025 | |
Jasper Therapeutics | Maintains: Buy | 60 40 | 5.87 | 581.43% | 8 | Jan 10, 2025 | |
Sana Biotechnology | Maintains: Strong Buy | 8 11 | 3.63 | 203.03% | 9 | Jan 8, 2025 | |
Acelyrin | Maintains: Neutral | 8 6 | 2.11 | 184.36% | 13 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 0.88 | 1263.64% | 11 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 3 20 | 3.35 | 497.01% | 13 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 7 7 | 0.87 | 704.6% | 11 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 15 15 | 0.39 | 3746.15% | 12 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | n/a | n/a | n/a | 16 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 6 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 115 115 | 64.58 | 78.07% | 12 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 9 9 | 2.94 | 206.12% | 3 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 12 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 1.05 | 1042.86% | 15 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 33 33 | 3.64 | 806.59% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 32 30 | 2.45 | 1124.49% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 9 9 | 0.85 | 958.82% | 10 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 22 22 | 5.53 | 297.83% | 10 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 0.82 | 1363.41% | 11 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 4 | 0.79 | 406.33% | 6 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 18 | 2.21 | 714.48% | 14 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 20 20 | 13.79 | 45.03% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 6 6 | 1 | 500% | 10 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 8 | 1.05 | 661.9% | 4 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 1 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 13 10 | n/a | n/a | 6 | Dec 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 48 | n/a | n/a | 8 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Dec 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 16 | n/a | n/a | 1 | Apr 13, 2022 |